Home Article BioScrip, Option Care merger approved

BioScrip, Option Care merger approved

BioScrip, Option Care merger approved

Also Noted

Default Author Head Shot

By HME News Staff

Updated Fri August 2, 2019

DENVER - BioScrip stockholders today approved the merger with Option Care. The merger is expected to close on or about Aug. 6. BioScrip and OptionCare announced their merger in March. John Rademacher will be CEO of the combined company and BioScrip President and CEO Dan Greenleaf will be special adviser to the company's board chairman, Henry Kraemer.

Comments

To comment on this post, please log in to your account or set up an account now.